Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03912571 · ClinicalTrials.gov registry record
Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment
A clinical trial of Sleep Disorder, sponsored by NYU Langone Health.
- Completed
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT03912571: Completed study of Sleep Disorder, sponsored by NYU Langone Health.
NCT03912571 is a study of Sleep Disorder that has completed, run by NYU Langone Health. The registered enrollment target is 28 participants, below the 161-participant average among 22 other Sleep Disorder trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03912571, a study of Sleep Disorder, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the sleep patterns of subjects with or without sleep disturbances (insomnia, sleep apnea) and compare these findings with their previous FDG/PIB PET, structural MRI and brain blood flow scams performed during their participation in the Following studies 'Alzheimer's Disease Core Center (ADCC) Clinical Evaluation' (IRB: 2942), MRI Progression Markers of Cognitive Decline in the Elderly' (IRB:09-0586), or 'Imaging Neuro inflammation in Alzheimer's Disease with \[11C\] Arachidonic Acid (AA) and PET'(IRB: 10-00442).
Primary Outcome
Measured by perfusion MRI
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Structural 3T MRI
- DIAGNOSTIC_TEST MRI Based Perfusion Imaging
- DIAGNOSTIC_TEST VR-CO2 MRI Scans
Study Locations (1)
New York
- NYU Langone Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-11-13 |
| Est. Completion | 2019-09 |
What the finished NCT03912571 record still lists
NCT03912571 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 161-participant average among 22 other Sleep Disorder trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Sleep Disorder appearing as the primary indexed condition, and to 3 interventions - of which Structural 3T MRI is the first listed.
NCT03912571 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03912571 about?
NCT03912571 is a clinical study titled "Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment". The purpose of this study is to determine the sleep patterns of subjects with or without sleep disturbances (insomnia, sleep apnea) and compare these findings with their previous FDG/PIB PET, structural MRI and brain blood flow scams performed during their participation in the Following studies 'Alz...
What is the current status of trial NCT03912571?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2011-11-13. Estimated completion is 2019-09.
What conditions does trial NCT03912571 study?
This clinical trial studies the following conditions: Sleep Disorder.
What interventions are being tested in trial NCT03912571?
The interventions under investigation include: Structural 3T MRI (DIAGNOSTIC_TEST), MRI Based Perfusion Imaging (DIAGNOSTIC_TEST), VR-CO2 MRI Scans (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03912571?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03912571 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03912571's enrollment target sits among peer trials
28 20th of 22 higher than 3 of 22 other Sleep Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
RECRUITING · Phase 3
-
Study of Disrupted Sleep in Somali Americans
RECRUITING
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
RECRUITING · NA
-
Baker Gordon Syndrome Natural History Study
RECRUITING
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI